Breaking Down Wanxiang Qianchao Co.,Ltd. Financial Health: Key Insights for Investors

Investors watching Wanxiang Qianchao Co., Ltd. will find a mixed but compelling picture: the company reported CNY 3.50 billion in revenue for the quarter ending September 30, 2025 - a sequential uptick of +15.75% as the TTM revenue reached CNY 13.89 billion (up 8.61% YoY) after a weaker 2024 annual revenue of CNY 12.87 billion (-11.17% vs. 2023); profitability shows improvement with H1 2025 net income of CNY 534.8 million (vs. CNY 489.28 million a year earlier), basic EPS rising to CNY 0.162, TTM net income of CNY 1.01 billion and TTM EPS of CNY 0.30, while efficiency metrics register ROE at 10.73% and ROA at 2.97%; the balance sheet reflects total assets of CNY 20.89 billion, total liabilities of CNY 11.84 billion and total equity of CNY 9.05 billion (debt-to-equity 0.71) with a current ratio of 1.28 and a quick ratio of 0.96, interest coverage of 4.82 and a 2025 impairment provision of CNY 155 million that trimmed first-half profits - yet valuation sits at a premium (TTM P/E 42.58, P/B 4.48, EV/EBITDA 21.38, EV/FCF 27.85, enterprise value ~CNY 42.02 billion) as management advances a major acquisition to buy 100% of Wanxiang America Corporation via share issuance and cash (fundraising to up to 35 specific investors), subject to due diligence and regulatory and shareholder approvals, making this a pivotal moment to dig into the details.

Wanxiang Qianchao Co.,Ltd. (000559.SZ) - Revenue Analysis

Wanxiang Qianchao reported stronger top-line momentum in 2025 after a revenue decline in 2024. Key reported figures and trend observations are summarized below.

• Q3 2025 quarterly revenue (CNY 3.50B) shows a notable rebound with a 15.75% sequential increase, signaling improving demand or operational recovery.
• TTM revenue of CNY 13.89B and an 8.61% YoY increase suggest the company is regaining growth momentum after 2024's contraction.
• Despite the bounce in 2025, 2024 annual revenue declined by 11.17% to CNY 12.87B - a reminder that recovery is recent and may be uneven.

• Revenue per employee (~CNY 1.59M) provides a productivity benchmark; compare this to peers in automotive components and manufacturing to assess operational efficiency.
• Market cap of CNY 38.99B and P/S of 2.81 reflect investor valuation relative to sales - the P/S implies moderate market expectations for continued revenue recovery and margin improvement.

Revenue drivers and near-term considerations:

• Order intake and production ramp-ups in key product lines likely contributed to the sequential revenue gain in Q3 2025.
• Macro demand in end markets (automotive, EV components) and supply-chain normalization are potential tailwinds for sustained TTM growth.
• Monitor margin trends and backlog conversion to validate whether revenue growth translates into earnings expansion.

For broader context on the company's strategy and business model, see: Wanxiang Qianchao Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Wanxiang Qianchao Co.,Ltd. (000559.SZ) - Profitability Metrics

• Net income for H1 2025: CNY 534.8 million (H1 2024: CNY 489.28 million).
• Basic EPS for H1 2025: CNY 0.162 (H1 2024: CNY 0.148).
• TTM net income: CNY 1.01 billion; TTM EPS: CNY 0.30.
• Return on equity (ROE): 10.73%.
• Return on assets (ROA): 2.97%.
• Profit margins: improved in 2025, indicating enhanced operational efficiency.

• EPS growth (H1 YoY): +9.5% (0.162 vs. 0.148) - supports stronger per-share returns to investors.
• Net income growth (H1 YoY): +9.3% (534.8M vs. 489.28M) - indicates higher absolute profitability.
• ROE at 10.73% signals effective use of equity capital; ROA at 2.97% shows moderate asset productivity consistent with capital-intensive operations.
• TTM figures (Net income CNY 1.01B; EPS CNY 0.30) provide a multi-quarter perspective that confirms sustained earnings versus single-period volatility.

Wanxiang Qianchao Co.,Ltd. (000559.SZ) - Debt vs. Equity Structure

Key balance-sheet metrics as of December 31, 2023 show a company with moderate leverage and generally adequate short-term liquidity, while inventory reliance limits immediate quick-liquidity flexibility.

• Total assets: CNY 20.89 billion
• Total liabilities: CNY 11.84 billion
• Total equity: CNY 9.05 billion

• Debt-to-equity = 11.84 / 9.05 ≈ 0.71 - indicates financial leverage is not excessive for a manufacturing/automotive-suppliers profile.
• Current ratio = Current assets / Current liabilities = 1.28 - short-term obligations appear coverable, but margin is not wide.
• Quick ratio = (Current assets - Inventory) / Current liabilities = 0.96 - suggests reliance on inventory to meet near-term cash needs.

For broader context on corporate history, ownership and business model: Wanxiang Qianchao Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Wanxiang Qianchao Co.,Ltd. (000559.SZ) - Liquidity and Solvency

Wanxiang Qianchao's short-term and long-term financial position can be summarized by its core liquidity and solvency metrics, recent impairment activity and the implications for near-term cash-flow resilience and creditor coverage.

• Current ratio 1.28: indicates adequate short-term asset coverage of current liabilities but not excessive liquidity slack.
• Quick ratio 0.96: signals potential reliance on inventory or slower-turning current assets to meet immediate obligations; below the conservative threshold of 1.0.
• Interest coverage 4.82: operating earnings cover interest expense nearly fivefold, reducing near-term solvency risk from debt servicing.

The CNY 155 million of impairment provisions recognized in 1H 2025 are split as follows:

• Credit impairment losses: CNY 26.41 million - reflects expected credit losses on receivables or financial assets.
• Asset impairment losses: CNY 129 million - indicates write-downs against property, plant, equipment or goodwill/intangible assets.
• Profit impact: Total profit for the period reduced by CNY 155 million, affecting profitability metrics and potentially covenant computations tied to reported earnings.

Implications for investors:

• Liquidity profile: While the current ratio suggests short-term coverage, the sub-1 quick ratio warrants monitoring of working capital composition and inventory turnover.
• Solvency profile: Interest coverage of 4.82 provides a margin of safety for interest payments, but sustained declines in operating income could compress this ratio.
• Asset quality: The sizable asset impairment (CNY 129 million) coupled with credit provisions indicates management is proactively addressing potential asset deterioration, which can be positive for transparency but reduces near-term earnings.

For additional context on the company's background and how these financial dynamics fit into its broader strategy, see: Wanxiang Qianchao Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money

Wanxiang Qianchao Co.,Ltd. (000559.SZ) - Valuation Analysis

The following snapshot captures current market valuation metrics for Wanxiang Qianchao Co.,Ltd., highlighting a premium market pricing that may reflect investor expectations around growth, profitability and cash generation.

• TTM Price-to-Earnings (P/E): 42.58 - indicates investors are paying a high multiple for reported earnings.
• Price-to-Book (P/B): 4.48 - the market values equity at multiple of book value, signaling premium intangible or growth expectations.
• EV/EBITDA: 21.38 - enterprise value relative to operating cash earnings suggests elevated valuation versus peers.
• EV/FCF: 27.85 - market places a substantial premium on the company's free cash flow conversion.
• Market Capitalization: CNY 43.03 billion; Enterprise Value: CNY 42.02 billion - comparable EV and market cap reflect moderate net debt position.

Key valuation takeaways:

• The suite of metrics (P/E, P/B, EV/EBITDA, EV/FCF) consistently points to a premium valuation.
• Premium multiples may be justified by above-market growth expectations, superior margins, proprietary technology, or favorable contract pipelines.
• Investors should compare these multiples to sector peers and assess sustainability of margins, capital expenditure needs, and free cash flow conversion.

For context on shareholder composition and investor activity related to these valuation dynamics, see: Exploring Wanxiang Qianchao Co.,Ltd. Investor Profile: Who's Buying and Why?

Wanxiang Qianchao Co.,Ltd. (000559.SZ) Risk Factors

• H1 2025 impairment losses: CNY 155.41 million total, comprising CNY 26.41 million in credit impairment losses and CNY 129.00 million in asset impairment losses.
• Impact on profitability: the provision for impairment losses reduced total profit for H1 2025 by CNY 155.41 million.

• Liquidity risk: quick ratio of 0.96 is below the commonly cited 1.0 benchmark, signaling potential short‑term liquidity pressure if working capital demands rise.
• Leverage profile: debt-to-equity at 0.71 reflects moderate leverage but leaves limited headroom if earnings weaken or if further asset write‑downs are required.
• Valuation risk: a TTM P/E of 42.58 implies investors are pricing growth or stability at a premium; downside to earnings could lead to sharp multiple contraction.
• Market sizing: market cap (CNY 43.03bn) vs EV (CNY 42.02bn) suggests net cash/other adjustments are modest and the company's capital structure should be monitored relative to impairments.
• Profitability sensitivity: the CNY 155.41 million impairment hit demonstrates earnings vulnerability to asset quality and credit performance deteriorations.

Wanxiang Qianchao Co.,Ltd. (000559.SZ) - Growth Opportunities

• Target: 100% equity acquisition of Wanxiang America Corporation.
• Financing mix: combination of share issuance to no more than 35 specific investors and direct cash payment.
• Fundraising cap via share issuance: up to RMB 2.5 billion (company disclosure limit for the specific-placement tranche).
• Indicative cash consideration: RMB 800 million payable on closing (subject to final valuation and adjustment).
• Share issuance size (indicative): issuance of ~150 million new shares (dilution and final price to be set by pricing benchmark date).
• Governance and approvals required: shareholder approval, Shenzhen Stock Exchange consent, and China Securities Regulatory Commission (CSRC) filing/approval.
• Process status: ongoing due diligence, external audit and independent valuation work in progress; board meeting to be scheduled to deliberate transaction specifics and disclose pricing benchmark date.

• Geographic diversification: acquisition builds North American manufacturing/sales footprint, aiming to increase USD-denominated revenue and reduce domestic market concentration risk.
• Scale and cross-selling: potential to integrate Wanxiang America's product lines with Wanxiang Qianchao's existing offerings to improve utilization and margin uplift.
• Funding structure: targeted private placement to ≤35 investors limits distribution complexity but will dilute existing holders by the issuance amount (indicative ~150 million new shares).
• Valuation sensitivity: final consideration and share price will hinge on audit/valuation outcomes and the pricing benchmark date disclosed at the board meeting.

• Completion of independent valuation report and external audit adjustments.
• Board meeting date and disclosure of the pricing benchmark date.
• Shareholder vote scheduling and vote results.
• Regulatory filings and approval timelines from Shenzhen Stock Exchange and CSRC.
• Definitive closing terms including final cash amount, exact share issuance volume, and any earn-outs or contingent consideration.